|
Atomistry » Fluorine » PDB 4c6l-4cqj » 4cbt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4c6l-4cqj » 4cbt » |
Fluorine in PDB 4cbt: Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons DiseaseEnzymatic activity of Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
All present enzymatic activity of Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease:
3.5.1.98; Protein crystallography data
The structure of Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease, PDB code: 4cbt
was solved by
R.W.Burli,
C.A.Luckhurst,
O.Aziz,
K.L.Matthews,
D.Yates,
K.A.Lyons,
M.Beconi,
G.Mcallister,
P.Breccia,
A.J.Stott,
S.D.Penrose,
M.Wall,
M.Lamers,
P.Leonard,
I.Mueller,
C.M.Richardson,
R.Jarvis,
L.Stones,
S.Hughes,
G.Wishart,
A.F.Haughan,
C.Oconnell,
T.Mead,
H.Mcneil,
J.Vann,
J.Mangette,
M.Maillard,
V.Beaumont,
I.Munoz-Sanjuan,
C.Dominguez,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4cbt:
The structure of Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
(pdb code 4cbt). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease, PDB code: 4cbt: Jump to Fluorine binding site number: 1; 2; 3; Fluorine binding site 1 out of 3 in 4cbtGo back to![]() ![]()
Fluorine binding site 1 out
of 3 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Fluorine binding site 2 out of 3 in 4cbtGo back to![]() ![]()
Fluorine binding site 2 out
of 3 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Fluorine binding site 3 out of 3 in 4cbtGo back to![]() ![]()
Fluorine binding site 3 out
of 3 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Reference:
R.W.Burli,
C.A.Luckhurst,
O.Aziz,
K.L.Matthews,
D.Yates,
K.A.Lyons,
M.Beconi,
G.Mcallister,
P.Breccia,
A.J.Stott,
S.D.Penrose,
M.Wall,
M.B.A.C.Lamers,
P.Leonard,
I.Mueller,
C.M.Richardson,
R.Jarvis,
L.Stones,
S.Hughes,
G.Wishart,
A.F.Haughan,
C.O'connell,
T.Mead,
H.Mcneil,
J.Vann,
J.Mangette,
M.Maillard,
V.Beaumont,
I.Munoz-Sanjuan,
C.Dominguez.
Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Histone Deacetylase (Hdac) Inhibitors As A Potential Therapy For Huntington'S Disease. J.Med.Chem. V. 56 9934 2013.
Page generated: Mon Jul 14 20:57:35 2025
ISSN: ISSN 0022-2623 PubMed: 24261862 DOI: 10.1021/JM4011884 |
Last articlesFe in 2YXOFe in 2YRS Fe in 2YXC Fe in 2YNM Fe in 2YVJ Fe in 2YP1 Fe in 2YU2 Fe in 2YU1 Fe in 2YQB Fe in 2YOO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |